IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Karyopharm Therapeutics Inc

Q2 2025 vs Q3 2025

Comparing institutional holders between quarters

Quarters

Q3 2025Q2 2025Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Braidwell LP
UNCHANGED
Shares48,482,000 from 48,482,000
Change0 (0%)
Value$35.0M (-$581.8K)
Filed 2025-11-14
Highbridge Capital Management LLC
UNCHANGED
Shares23,625,000 from 23,625,000
Change0 (0%)
Value$17.7M ($0)
Filed 2025-11-10
Context Capital Management, LLC
UNCHANGED
Shares8,871 from 8,871
Change0 (0%)
Value$6.4M (+$1.4M)
Filed 2025-11-12
Proequities, Inc.
N/A
Shares— from 0
Change0
Value—
Status
Braidwell LP
UNCHANGED48,482,00048,482,00000%$35.5M$35.0M-$581.8K2025-11-14
Highbridge Capital Management LLC
UNCHANGED23,625,00023,625,00000%$17.7M$17.7M$02025-11-10
Context Capital Management, LLC
UNCHANGED8,8718,87100%$5.0M$6.4M+$1.4M2025-11-12
Proequities, Inc.
N/A—00—$0———
Showing 4 of 4 institutions